InjazAI

Science Corporation, led by Max Hodak, has implanted its PRIMA vision-restoring chip in the first Stargardt disease patient as part of its path toward brain-computer interfaces.

1 min read

Science Corporation Implants Vision-Restoring PRIMA Chip in First Stargardt Disease Patient

PRIMA Chip Implanted in First Patient

FAQ

What is Stargardt disease?

Stargardt disease is an inherited retinal disorder that causes progressive loss of central vision, typically affecting children and young adults.

What is the PRIMA chip?

PRIMA is an implantable chip designed to restore vision in patients with degenerative retinal diseases, developed by Science Corporation.

How does Science's approach differ from Neuralink?

While Neuralink focuses on broad brain interfaces, Science starts with specific vision restoration applications before expanding to broader brain-computer interfaces.

Can patients in the Middle East access this technology?

The company has not announced expansion plans for the Middle East yet, but initial clinical trials may pave the way for future approvals in the region.

Source: TechCrunch AI

AI-assisted summary of the source above. High-confidence stories publish automatically; others wait for review. Facts that are not in the source are not added.